AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00761618 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Chest X-Ray
Description: Chest X-Rays at 3 and 6 month follow up visits
Study NCT02828592 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: 30 mg/m2 IV QD x 5 days (Days -6 to -2)
Study NCT04138849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BBT-877 single dose
Description: Oral capsule, single dose.
Study NCT04138849 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo single dose
Description: Oral capsule, single dose.
Study NCT06754254 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: blood biomarkers from the internal jugular vein
Description: blood biomarkers (Aβ42/40, p-tau217, p-tau181, NFL, GFAP, etc.) from the internal jugular vein
Study NCT04468971 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CK0802
Description: Cryopreserved, off the shelf, cord blood derived T regulatory cells
Study NCT04468971 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Expicient
Study NCT02367053 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZP4207
Study NCT02367053 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glucagon
Study NCT04064229 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ivWatch Model 400 with SmartTouch Sensor
Description: The ivWatch Model 400 with SmartTouch Sensor monitored the site during the course of the infiltration and issued red and/or yellow notifications if an infiltration was detected.
Study NCT04064229 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ivWatch Model 400 with Fiber Optic Sensor
Description: The ivWatch Model 400 with Fiber Optic Sensor monitored the site during the course of the infiltration and issued red and/or yellow notifications if an infiltration was detected.
Study NCT00836927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ridaforolimus Tablet
Description: Ridaforolimus 10 mg oral tablet
Study NCT00836927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ridaforolimus Intravenous (IV) Infusion
Description: Ridaforolimus IV infusion administered once daily for 5 days every 2 weeks in a 28-day cycle (two 2-week courses equals 1 cycle).
Study NCT00490061 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lapatinib
Description: 1500 mg po daily orally
Study NCT00490061 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiotherapy (radiation)
Description: Standard of Care
Study NCT00490061 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: G.E. Healthcare 1.5T MR, systems revision 12.0 M5
Description: Standard of Care, used to deliver IMRT
Study NCT00490061 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DCE-MRI
Description: A subset of patients received imaging before and after Lapatinib loading, prior to starting radiotherapy.
Study NCT04399135 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Orthopantomogram X-ray view
Description: taking an X-ray to determine bone loss level and attachment loss level for periodontitis classification
Study NCT04399135 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Endo-Ice
Description: Included teeth will be dried with 4x4 gauze then tested with a cold test using Endo-Ice.
Study NCT04399135 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Electric Pulp Tester (EPT)
Description: Included teeth will be dried with 4x4 gauze then tested with an Electric test using electric pulp tester (EPT).
Study NCT06752837 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tornado rotary system
Description: In arm one, stainless steel tornado files works by high-speed rotation that influences the fluid dynamics within the canal and improves irrigation efficiency. Canals are finished with a file having a 4% taper and an apical diameter of 0.25 mm.
Study NCT06752837 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WaveOne rotary system
Description: In arm two, WaveOne system is a single reciprocating file system with a heat-treated NiTi Memory Wire (M Wire).It has a taper of 0.08 in apical 3 mm, with a tip diameter of 0.25 mm. in a torque control endodontic handpiece (X smart plus with reciprocation mode)
Study NCT06752837 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OneShape rotary system
Description: In arm three, OneShape system utilizes a conventional, continuous rotational motion. It has asymmetric cross-sectional geometry, and traveling waves of motion that are produced along the file's active region. It has a single constant taper of 0.06 and a tip size of 25 with distinct cross-sectional designs along the whole length of the working parts
Study NCT06752837 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cone beam computed tomography
Description: A post-operative CBCT image was obtained and compared to the pre-operative one to assess the impact of canal preparation of each file on the periapical lesion.
Study NCT00766636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Arm A:~1000 mg/M\^2 given intravenously over 100 min. every week for 6 doses beginning day 1 (days 1, 8, 15, 22, 29, 36) +/- 1 day.~Arm B:~400 mg/M\^2 given intravenously over 40 min. every week for 6 doses beginning day 1 (days 1, 8, 15, 22, 29, 36) +/- 1 day.
Study NCT02828592 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: 14.5 mg/kg/day IV x 2 doses (Days -6 \& -5)
Study NCT02828592 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Total Body Irradiation
Description: 300 cGy x1 dose (Day -1)
Study NCT02828592 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabbit ATG
Description: 1.5 mg/kg/day x 3 days (Days -3 to -1)
Study NCT02828592 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Post-transplant: 50 mg/kg IV QD (Day +3 to +4)
Study NCT01885377 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Specific exercise group
Description: A program where exercise load is individually adjusted and the exercises progressed during a 3 month period. The 'pain monitoring model' were used to find the individual resistance. Several exercises are performed eccentrically in order to load more. Initially the exercises were PT-tutored every week and then every other week.
Study NCT01885377 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control exercise group
Description: A program with movements to maintain flexibility in the neck and shoulder muscles. Initially PT-tutored every week and then every other week.
Study NCT01903538 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (tDCS)
Description: Cathodal transcranial direct current stimulation (tDCS) 20min, 1mA, F3 (EEG 10/20), reference right M. deltoideus
Study NCT01903538 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham transcranial direct current stimulation
Description: Sham transcranial direct current stimulation (tDCS) 40s, 1mA, F3 (EEG 10/20), reference right M. deltoideus
Study NCT04368429 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine (MenACYW Conjugate Vaccine)
Description: Pharmaceutical form: Liquid solution Route of administration: IM
Study NCT04368429 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Description: Pharmaceutical form: Liquid solution Route of administration: IM
Study NCT02498483 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: Infants will receive 15 mg/kg of acetaminophen.
Study NCT00222534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Study NCT00222534 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02247609 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Anti-CD19 CAR T cells
Description: Autologous 4th generation withdrawable lentiviral-transduced anti-CD19-CAR T cells
Study NCT01746693 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dynamic Vessel Analyzer
Description: retinal vessel diameter, retinal oxygen saturation
Study NCT01746693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laser Doppler Velocimetry
Description: retinal blood flow velocity, retinal blood flow
Study NCT01746693 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 7-Tesla MRI
Description: High resolution functional and anatomical imaging of the visual pathway
Study NCT01746693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pattern electroretinography
Description: inner retinal function
Study NCT01746693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fourier domain optical coherence tomography
Description: Blood flow in retina.
Study NCT03078270 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: botulinum toxin A
Description: Single treatment visit for 5 injections of botulinum toxin A, 40 units (for females) and 50 units (for males)/
Study NCT03078270 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: botulinum toxin A
Description: Single treatment visit for 5 injections of botulinum toxin A, 40 units (for females) and 50 units (for males)/
Study NCT03078270 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: single treatment visit for 5 injections of normal saline
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Synovial Alpha-defensin assay
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Synovial Alpha-defensin assay
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Synovial Neutrophil elastase assay
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Synovial Neutrophil elastase assay
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Synovial lactate assay
Description: Synovial Fluid (joint fluid) will be sent out to CD Diagnostics for this test.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Synovial lactate assay
Description: Synovial Fluid (joint fluid) will be sent out to CD Diagnostics for this test.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Synovial C-reactive Protein (CRP)
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Synovial C-reactive Protein (CRP)
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Synovial Staphylococcus spp antigen panel
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Synovial Staphylococcus spp antigen panel
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Synovial Candida spp antigen panel
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Synovial Candida spp antigen panel
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Synovial Enterococcus faecalis assay
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Synovial Enterococcus faecalis assay
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Synovial bacterial culture by BacT/Alert
Description: The synovial fluid (joint fluid) sent to CD Diagnostics for testing will also be cultured to see if any organisms grow.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Synovial bacterial culture by BacT/Alert
Description: The synovial fluid (joint fluid) sent to CD Diagnostics for testing will also be cultured to see if any organisms grow.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Synovial Cell count + differential (CBC)
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Synovial Cell count + differential (CBC)
Description: One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Synovial Gram Stain
Description: This will be performed by CD Diagnostics if any organisms are present in the synovial fluid.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Synovial Gram Stain
Description: This will be performed by CD Diagnostics if any organisms are present in the synovial fluid.
Study NCT00766636 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: 1 time each day for 5 days in a row for 5 1/2 weeks starting on Day 1 for a total of 50.4 Gy.
Study NCT00766636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erlotinib
Description: 100 mg daily by mouth on days 1-42.
Study NCT00766636 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: Surgical removal of the pancreas and duodenum
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Synovial Leukocyte Esterase Test Strips
Description: These test strips will be tested at the hospital where the patient is being seen, a few drops of synovial fluid will be used on the strip.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Synovial Leukocyte Esterase Test Strips
Description: These test strips will be tested at the hospital where the patient is being seen, a few drops of synovial fluid will be used on the strip.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Synovial PCR for Kingella kingae
Description: In participants \< 8 years old, a sample of synovial fluid will be tested for Kingella kingae using PCR.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Synovial PCR for Kingella kingae
Description: In participants \< 8 years old, a sample of synovial fluid will be tested for Kingella kingae using PCR.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Serum Cell count + differential (CBC)
Description: A blood test performed at the hospital.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Serum Cell count + differential (CBC)
Description: A blood test performed at the hospital.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Serum erythrocyte sedimentation rate (ESR)
Description: A blood test performed at the hospital.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Serum erythrocyte sedimentation rate (ESR)
Description: A blood test performed at the hospital.
Study NCT00452582 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sildenafil (Viagra)
Description: Dose escalation (one of the following): 25 mg daily for 2 weeks, 50 mg daily for 2 weeks, 75 mg daily for 2 weeks, 50 mg twice daily for two weeks, 50 mg AM and 75 mg PM for 2 weeks, 75 mg twice daily for 2 weeks, 75 mg in AM and 100 mg in PM for 2 weeks, 100 mg twice daily for 2 weeks.
Study NCT00452582 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Physical therapy, occupational therapy, speech therapy
Study NCT00511914 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: cTIV
Description: One dose (0.5 mL) of cell culture-derived influenza vaccine, administered in the deltoid muscle
Study NCT00952159 — intervention group
Intervention type: BIOLOGICAL
Intervention: Monitoring seric concentrations of O-demethyl-tramadol and tramadol
Description: The first aim of this study is the validation of monitoring seric concentrations of O-demethyl-tramadol and tramadol to make the ratio in order to detect CYP2D6 poor metabolizers in therapeutic situation, comparing the result with genotyping. The finding of a poor metabolizer status in a patient will make the choice of analgesic drugs easier, avoiding tramadol and codeine. The final objective of this research is to be able to determine the CYP2D6 phenotype in a patient treated by tramadol without a good analgesia. By a single take of blood and a rapid response, this method should be liked to improve pain management. Furthermore, CYP2D6 phenotyping is interesting for the patient because many other drugs depend on this way of metabolism.
Study NCT02638584 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ilaprazole
Description: Ilaprazole 10mg 2tablets once a day(1 times / day), before breakfast
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Serum C-reactive Protein (CRP)
Description: A blood test performed at the hospital.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Serum C-reactive Protein (CRP)
Description: A blood test performed at the hospital.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Serum D-dimer
Description: A blood test performed at the hospital.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Serum D-dimer
Description: A blood test performed at the hospital.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Serum Procalcitonin
Description: A blood test performed at the hospital.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Serum Procalcitonin
Description: A blood test performed at the hospital.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood Cultures
Description: Blood will be cultured at the hospital to see if any organisms grow.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Blood Cultures
Description: Blood will be cultured at the hospital to see if any organisms grow.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Optional blood testing per standard of care (ASO, anti-strep, ANA, anti-DS-DNA, HLA-B27, RF, Lyme and other inflammatory/ rheumatologic markers )
Description: In patients with suspected inflammation/infection, there are other blood tests which may be standard of care and used for diagnosis.
Study NCT03704766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Optional blood testing per standard of care (ASO, anti-strep, ANA, anti-DS-DNA, HLA-B27, RF, Lyme and other inflammatory/ rheumatologic markers )
Description: In patients with suspected inflammation/infection, there are other blood tests which may be standard of care and used for diagnosis.
Study NCT00527566 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Description: IV mepolizumab, 750 mg
Study NCT00783926 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: H5N1 Influenza Vaccine, Whole virion, Vero cell-derived, Inactivated Influenza Vaccine, non-adjuvanted (reverse genetic reassortant/H5N1 hemagglutinin antigen)
Description: 2 x 0.5 mL intramuscular injections 21 days apart (one of six different doses of hemagglutinin antigen without adjuvant)
Study NCT00974324 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: endostar and CHOP
Description: endostar, 7.5m g/m2, intravenous, Day 2-15, repeat every 3 weeks~CHOP: Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone
Study NCT01914094 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prehab
Study NCT02800850 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bright Light
Study NCT02800850 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Light